Because the brain receives less blood for a short period, the vestibular system (balance organ) can generate the sensation of dizziness or vertigo. The condition is usually benign, but in some people it signals an underlying disorder that requires treatment.

Sources: Mayo Clinic; American Heart Association; NICE guideline NG136.

Common Causes

Orthostatic hypotension can be primary (no identifiable cause) or secondary to other medical conditions, medications, or lifestyle factors. Below are the most frequently encountered causes, grouped by category.

• Dehydration or volume depletion – caused by excessive sweating, fever, vomiting, diarrhea, or inadequate fluid intake.
• Medications – especially antihypertensives, diuretics, alpha‑blockers, nitrates, tricyclic antidepressants, and some Parkinson’s drugs.
• Cardiovascular disorders – heart failure, arrhythmias, aortic stenosis, myocardial infarction, or valvular disease that limit cardiac output.
• Autonomic nervous system failure – seen in Parkinson’s disease, multiple system atrophy, pure autonomic failure, and diabetic autonomic neuropathy.
• Endocrine abnormalities – adrenal insufficiency (Addison’s disease), hypothyroidism, and pheochromocytoma.
• Blood loss – acute hemorrhage from trauma, gastrointestinal bleeding, or heavy menstrual periods.
• Prolonged bed rest or immobility – deconditioning reduces the ability of veins to return blood to the heart.
• Alcohol or substance use – acute alcohol intoxication and certain recreational drugs cause vasodilation and volume loss.
• Physical compression of the abdominal/vascular area – tight clothing, abdominal binders, or large post‑prandial blood shifts can precipitate drops in pressure.
• Age‑related changes – older adults have stiffer arteries and reduced baroreceptor sensitivity, making them more prone to orthostatic drops.

Associated Symptoms

People with orthostatic hypotension often notice a cluster of other sensations, because the body’s compensatory mechanisms become overwhelmed. Common concurrent symptoms include:

• Blurry or dim vision (often described as “tunnel vision”).
• Weakness or fatigue, especially in the legs.
• Nausea, sometimes accompanied by a feeling of impending faint.
• Palpitations or a rapid heart rate (reflex tachycardia).
• Cold, clammy skin.
• Headache, typically mild and brief.
• Difficulty concentrating or “brain fog”.
• Syncope (fainting) if the pressure drop is severe or prolonged.

When to See a Doctor

Most episodes are short‑lived and resolve with simple measures, but you should schedule a medical evaluation if any of the following apply:

• Episodes occur more than once a week or interfere with daily activities.
• The dizziness lasts longer than a minute, or you actually lose consciousness.
• Symptoms are accompanied by chest pain, shortness of breath, or palpitations.
• You have a known heart condition, diabetes, or neurologic disease.
• There is sudden, unexplained weight loss or persistent vomiting/diarrhea.
• Medication changes have been made recently and dizziness began thereafter.

Prompt evaluation is especially important for older adults, because orthostatic hypotension is a leading cause of falls in this population.

Diagnosis

Diagnosing orthostatic hypotension is a stepwise process that combines a focused history, physical examination, and targeted tests.

1. Clinical History

• Pattern of dizziness (time of day, triggers, duration).
• Medication list (including over‑the‑counter and herbal supplements).
• Recent fluid loss, illness, or changes in diet.
• Comorbid conditions (cardiac, endocrine, neurologic).

2. Orthostatic Vital Sign Measurement

Patients rest supine for at least five minutes, then blood pressure and heart rate are recorded while lying down, at one minute, and at three minutes after standing. A drop meeting the definition above confirms orthostatic hypotension.

3. Laboratory Tests

• Complete blood count (CBC) – to rule out anemia or bleeding.
• Basic metabolic panel – evaluates electrolytes and kidney function.
• Serum cortisol and ACTH – if adrenal insufficiency is suspected.
• Thyroid‑stimulating hormone (TSH) – to assess hypothyroidism.
• HbA1c – screen for diabetes‑related autonomic neuropathy.

4. Cardiac Evaluation

• Electrocardiogram (ECG) – looks for arrhythmias, conduction disease.
• Echocardiography – assesses ejection fraction, valvular disease.
• Holter monitor or event recorder if intermittent tachycardia/fainting is reported.

5. Autonomic Testing (when indicated)

• Head‑up tilt table test – reproduces the orthostatic stress under controlled conditions.
• Valsalva maneuver and deep‑breathing tests – evaluate baroreflex sensitivity.

6. Imaging (rarely needed)

If neurologic causes are suspected, MRI of the brain or spine may be ordered.

Treatment Options

Therapy is individualized, aiming first at reversible lifestyle or medication factors, then at underlying disease processes, and finally at symptomatic relief.

Non‑pharmacologic Measures

• Fluid and salt intake – increase to 2–3 L of water daily and 3–5 g of sodium (unless contraindicated by heart/kidney disease).
• Compression garments – thigh‑high or waist‑high compression stockings (30–40 mmHg) improve venous return.
• Gradual position changes – sit up on the edge of the bed for a minute before standing; use a “post‑ural” technique (stand slowly, bend knees slightly).
• Physical counter‑maneuvers – crossing legs, tensing calf muscles, or performing the “abdominal pump” while standing.
• Elevate the head of the bed – 10–20° tilt at night reduces nocturnal fluid pooling.

Medication Adjustments

• Review and possibly lower doses of antihypertensives, diuretics, or vasodilators.
• Switch to longer‑acting agents that have less abrupt blood‑pressure effects.

Pharmacologic Therapies

• Midodrine (α‑agonist) – increases peripheral vascular tone; typically 2.5–10 mg PO three times daily, avoided at bedtime.
• Fludrocortisone (mineralocorticoid) – expands plasma volume by promoting sodium and water retention; 0.1–0.2 mg daily, monitor potassium and blood pressure.
• Droxidopa – norepinephrine prodrug approved for neurogenic orthostatic hypotension; titrated to effect.
• In selected neurogenic cases, pyridostigmine (acetylcholinesterase inhibitor) can modestly improve autonomic reflexes.

All medications require careful titration and periodic lab monitoring (electrolytes, renin‑angiotensin activity) to avoid hypertension or fluid overload.

Management of Underlying Conditions

Treat the root cause whenever possible—e.g., initiate insulin or oral agents for diabetes, replace adrenal steroids for Addison’s disease, or adjust Parkinson’s therapy.

Prevention Tips

Even if you have already experienced orthostatic dizziness, many habits can reduce recurrence.

• Stay well‑hydrated; carry a water bottle and sip regularly, especially on hot days.
• Consume a moderate amount of salt unless you have heart failure or chronic kidney disease—consult your provider.
• Exercise daily (walking, calf‑raise sets, resistance training) to strengthen the muscle pump that pushes blood upward.
• Avoid alcohol and large, high‑carbohydrate meals right before standing; they cause vasodilation and “post‑prandial” hypotension.
• Wear compression stockings during prolonged standing (shopping, work shifts).
• Schedule medication doses so that the highest antihypertensive effect does not coincide with early morning rises.
• Use a night‑time pillow under the head of the bed to maintain a slight head‑up tilt.
• Check blood pressure at home in supine, sitting, and standing positions to catch early trends.

Emergency Warning Signs

References:

1. Mayo Clinic. Orthostatic hypotension. Accessed June 2026.
2. American Heart Association. Orthostatic Hypotension.
3. National Institute on Aging. Low Blood Pressure (Orthostatic Hypotension).
4. National Institute for Health and Care Excellence (NICE). NG136: Syncope and Transient Loss of Consciousness.
5. World Health Organization. Hypertension Fact Sheet.
6. Cleveland Clinic. Orthostatic Hypotension.
7. Freeman R, et al. “Diagnosis of Autonomic Failure.” Neurology. 2019;93(22):e2120‑e2132.
8. Shibao C, et al. “Management of Neurogenic Orthostatic Hypotension.” J Clin Hypertens. 2021;23(8):1185‑1193.